During the past decade, Alabama Orthopaedic Surgeons conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Orthopaedic Surgeons" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Orthopaedic Surgeons" are "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials), "Chronic Pain" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Alabama Orthopaedic Surgeons" in a lesser frequency.

Most popular intervention types in "Alabama Orthopaedic Surgeons" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tanezumab 2.5 mg" (2 trials), "Investigational Medical Product (IMP) administered in parent study" (1 trials), "NSAID" (1 trials), "Placebo" (1 trials) and "Tanezumab 2.5mg/5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Orthopaedic Surgeons" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Alabama Orthopaedic Surgeons". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Alabama Orthopaedic Surgeons, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Orthopaedic Surgeons, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".